![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Compassionate use of subcutaneously administered
REP 2139-Mg in cirrhotic HBV / HDV co-infection
|
|
|
AASLD 2022 Nov 4-8
Marc Bourliere1, Veronique Loustaud-Ratti2, Christiane Stern3, Michel Bazinet4, Souad Ben Ali1, Laurence Lecomte1, Sandrine Francois2, Cecilia de Freitas3, Athenaïs Gerber5, Segolene Brichler5, Emmanuel Gordien5, Andrew Vaillant
1. Service Hepato-Gastro-Enterologie, Hopital Saint-Joseph, Marseille, France, 2. Department Hepatogastroenterology, Centre hospitalier universitaire a Limoges, Limoges, France, 3. Department de Hepatologie, AP-HP Hopital Beaujon, Clichy, France
4. Replicor Inc. Montreal, Canada, 5. Centre national de reference des hepatite B, C et Delta - Laboratoire associe, Hopital Avicenne, Bobigny, France
![1114221](../images/111422/111422-12/1114221.gif)
![1114222](../images/111422/111422-12/1114222.gif)
![1114223](../images/111422/111422-12/1114223.gif)
![1114224](../images/111422/111422-12/1114224.gif)
![1114225](../images/111422/111422-12/1114225.gif)
![1114226](../images/111422/111422-12/1114226.gif)
![1114227](../images/111422/111422-12/1114227.gif)
![1114228](../images/111422/111422-12/1114228.gif)
![1114229](../images/111422/111422-12/1114229.gif)
![11142210](../images/111422/111422-12/11142210.gif)
![11142211](../images/111422/111422-12/11142211.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|